Auteurs
Analysis
UK
Racine
Analysis
UK
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Analysis (UK)

Index « Auteurs » - entrée « Alan R. Crossman »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Alan Prescott < Alan R. Crossman < Alan R. Kimmel  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000072 (2015) Matthieu F. Bastide [France] ; Wassilios G. Meissner [France] ; Barbara Picconi [Italie] ; Stefania Fasano [Italie] ; Pierre-Olivier Fernagut [France] ; Michael Feyder [Suède] ; Veronica Francardo [Suède] ; Cristina Alcacer [Suède] ; Yunmin Ding [États-Unis] ; Riccardo Brambilla [Italie] ; Gilberto Fisone [Suède] ; A. Jon Stoessl [Canada] ; Mathieu Bourdenx [France] ; Michel Engeln [France] ; Sylvia Navailles [France] ; Philippe De Deurwaerdère [France] ; Wai Kin D. Ko [France] ; Nicola Simola [Italie] ; Micaela Morelli [Italie] ; Laurent Groc [France] ; Maria-Cruz Rodriguez [Espagne] ; Eugenia V. Gurevich [États-Unis] ; Maryka Quik [États-Unis] ; Michele Morari [Italie] ; Manuela Mellone [Italie] ; Fabrizio Gardoni [Italie] ; Elisabetta Tronci [Italie] ; Dominique Guehl [France] ; François Tison [France] ; Alan R. Crossman [Royaume-Uni] ; Un Jung Kang [Suède] ; Kathy Steece-Collier [États-Unis] ; Susan Fox [Canada] ; Manolo Carta [Italie] ; M. Angela Cenci [Suède] ; Erwan Bézard [Royaume-Uni]Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.
000112 (2014) Wai Kin D. Ko [France] ; Marie-Laure Martin-Negrier [France] ; Erwan Bezard [France] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni]RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease.
000135 (2014) Mathieu Bourdenx [France] ; Anna Nilsson [Suède] ; Henrik Wadensten [Suède] ; Maria F Lth [Suède] ; Qin Li [République populaire de Chine] ; Alan R. Crossman [Royaume-Uni] ; Per E. Andrén [Suède] ; Erwan Bezard [République populaire de Chine]Abnormal structure-specific peptide transmission and processing in a primate model of Parkinson's disease and l-DOPA-induced dyskinesia.
000399 (2008) Birger Scholz [Suède] ; Marcus Svensson [Suède] ; Henrik Alm [Suède] ; Karl Sköld [Suède] ; Maria F Lth [Suède] ; Kim Kultima [Suède] ; Céline Guigoni [France] ; Evelyne Doudnikoff [France] ; Qin Li [République populaire de Chine] ; Alan R. Crossman [Royaume-Uni] ; Erwan Bezard [France] ; Per E. Andrén [Suède]Striatal Proteomic Analysis Suggests that First L-Dopa Dose Equates to Chronic Exposure
000447 (2007) Dieter Scheller [Allemagne] ; PIU CHAN [République populaire de Chine] ; QIN LI [Royaume-Uni] ; TAO WU [République populaire de Chine] ; RENLING ZHANG [République populaire de Chine] ; LE GUAN [République populaire de Chine] ; Paula Ravenscroft [Royaume-Uni] ; Celine Guigoni [France] ; Alan R. Crossman [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Erwan Bezard [France]Rotigotine treatment partially protects from MPTP toxicity in a progressive macaque model of Parkinson's disease
000453 (2006) Kim Kultima [Suède] ; Birger Scholz [Suède] ; Henrik Alm [Suède] ; Karl Sköld [Suède] ; Marcus Svensson [Suède] ; Alan R. Crossman [Royaume-Uni] ; Erwan Bezard [France] ; Per E. Andrén [Suède] ; Ingrid Lönnstedt [Suède]Normalization and expression changes in predefined sets of proteins using 2D gel electrophoresis: A proteomic study of L-DOPA induced dyskinesia in an animal model of Parkinson's disease using DIGE
000482 (2006) Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France]Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets : Mediation by D2, not D3, dopamine receptors
000535 (2004) Paula Ravenscroft [Royaume-Uni] ; Sylvie Chalon [France] ; Jonathan M. Brotchie [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni]Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia
000539 (2004) Erwan Bezard [France] ; Michael P. Hill [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Anne Michel [Belgique] ; Renee Grimee [Belgique] ; Henrik Klitgaard [Belgique]Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque
000549 (2003) Michael P. Hill [Royaume-Uni] ; Erwan Bezard [France] ; Steven G. Mcguire [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Ann Michel [Belgique] ; Renee Grimee [Belgique] ; Henrik Klitgaard [Belgique]Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset

List of associated KwdEn.i

Nombre de
documents		Descripteur
4Dyskinesia
4Levodopa
4Parkinson disease
3Animal
3Animals
3D2 Dopamine receptor
3D3 Dopamine receptor
2Animal model
2Antiparkinson Agents (adverse effects)
2Antiparkinson agent
2Dopamine
2Dyskinesia, Drug-Induced (physiopathology)
2Enkephalins (metabolism)
2Levetiracetam
2Levodopa (adverse effects)
2Monkey
2Nervous system diseases
2Protein Precursors (metabolism)
2Ropinirole
2Treatment
1Anticonvulsant
1Antiparkinson Agents (pharmacology)
1Antiparkinson Agents (toxicity)
1Autoradiography
1Cells, Cultured
1Central Nervous System (drug effects)
1Central Nervous System (physiopathology)
1Chemotherapy
1Clinical trial
1Combined treatment
1Comparative study
1Corpus Striatum (drug effects)
1Corpus Striatum (physiopathology)
1D1 Dopamine receptor
1Degeneration
1Dopamine agonist
1Dyskinesia, Drug-Induced (metabolism)
1Dyskinesia, Drug-Induced (therapy)
1Enkephalin
1Enkephalins (analysis)
1Ex vivo
1Experimental data
1Experimental study
1Female
1Functional Laterality
1Gene Expression (drug effects)
1Genetic Therapy
1Globus Pallidus (chemistry)
1Globus Pallidus (metabolism)
1Human
1Humans
1Levodopa (pharmacology)
1Levodopa (toxicity)
1Locus niger
1Macaca mulatta
1Male
1Mimic
1Models
1Motor control
1Neuropeptides (analysis)
1Neuropeptides (metabolism)
1Neurotoxin
1Nootropic agent
1Oligonucleotides, Antisense (administration & dosage)
1Opioid peptide
1Opioid receptor
1Oxidopamine
1Parkinson Disease (drug therapy)
1Parkinsonian Disorders (drug therapy)
1Parkinsonian Disorders (metabolism)
1Parkinsonian Disorders (physiopathology)
1Photon
1Precursor
1Prevention
1Protein Precursors (analysis)
1Psychotropic
1Putamen (chemistry)
1Putamen (metabolism)
1RGS Proteins (genetics)
1RGS Proteins (metabolism)
1RNA, Messenger (metabolism)
1Rats, Sprague-Dawley
1Rotigotine
1Single photon emission tomography
1Tachykinins (analysis)
1Tachykinins (metabolism)
1Toxicity
1Up-Regulation (drug effects)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/UK/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "Alan R. Crossman" 

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "Alan R. Crossman" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Alan R. Crossman
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024